Shares of 23andMe (NASDAQ: ME) imploded this week after the embattled genetic testing company filed for Chapter 11 bankruptcy and…
Read More »Biotech
Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, reported the closing…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH), a specialty pharmaceutical company dedicated to enhancing radiation therapy outcomes for cancer patients, has taken two…
Read More »
Small-cap stocks often deliver some of the most explosive gains when game-changing news hits the market. Investors searching for high-upside…
Read More »
Shuttle Pharmaceuticals (NASDAQ: SHPH) has filed its Annual Report on Form 10-K for the fiscal year ending December 31, 2024,…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced the completion of its clinical trial titled: “A Phase…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM), a biopharmaceutical company dedicated to building a portfolio of innovative…
Read More »
Shares of Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM), an up-and-coming biotech stock with a tiny float,…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced that its licensee, Celly Nutrition, the company behind unbuzzd™, the…
Read More »
Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) announced today the completion of its double-blind, randomized, placebo-controlled crossover…
Read More »